We are live on ! Find out more
NHC

Nicholas Hoffman & Company Portfolio holdings

AUM $4.74B
1-Year Est. Return 18.12%
This Fund
S&P 500
This Quarter Est. Return
+6.31%
1 Year Est. Return
+18.12%
3 Year Est. Return
+65.12%
5 Year Est. Return
+53.27%
10 Year Est. Return
+210.2%
AUM
$255M
AUM Growth
+$17.4M
Cap. Flow
+$3.23M
Cap. Flow %
1.27%
Top 10 Hldgs %
40.98%
Holding
173
New
9
Increased
70
Reduced
65
Closed
7

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$639K
2
CVX icon
Chevron
CVX
+$538K
3
GSK icon
GSK
GSK
+$425K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$359K
5
TSM icon
TSMC
TSM
+$339K

Sector Composition

Rank Sector Weight
1 Consumer Staples 12%
2 Technology 10.83%
3 Financials 9.85%
4 Healthcare 7.55%
5 Consumer Discretionary 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
76
CVS Health
CVS
$122B
$864K 0.34%
11,915
-2,442
-17% -$178K
VBR icon
77
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
$840K 0.33%
6,329
+3,982
+170% +$518K
GE icon
78
GE Aerospace
GE
$384B
$835K 0.33%
9,982
-1,115
-10% -$106K
NVS icon
79
Novartis
NVS
$297B
$812K 0.32%
10,793
-701
-6% -$52.9K
INTC icon
80
Intel
INTC
$513B
$810K 0.32%
17,550
+497
+3% +$21.7K
PFE icon
81
Pfizer
PFE
$153B
$806K 0.32%
23,445
+2
+0% +$68
DO
82
DELISTED
Diamond Offshore Drilling
DO
$787K 0.31%
42,315
-2,860
-6% -$46.5K
SCHB icon
83
Schwab US Broad Market ETF
SCHB
$44.9B
$778K 0.31%
72,342
+16,854
+30% +$177K
IVV icon
84
iShares Core S&P 500 ETF
IVV
$902B
$775K 0.3%
2,882
-108
-4% -$28.3K
MRK icon
85
Merck
MRK
$318B
$760K 0.3%
14,156
-1,040
-7% -$57.7K
META icon
86
Meta Platforms (Facebook)
META
$1.51T
$758K 0.3%
4,297
+220
+5% +$38.9K
GSK icon
87
GSK
GSK
$106B
$751K 0.29%
16,939
-9,199
-35% -$425K
RDS.A
88
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$751K 0.29%
11,264
-496
-4% -$31.3K
JPM icon
89
JPMorgan Chase
JPM
$950B
$739K 0.29%
6,912
+23
+0.3% +$2.33K
GL icon
90
Globe Life
GL
$14.3B
$719K 0.28%
7,921
-554
-7% -$47.5K
KHC icon
91
Kraft Heinz
KHC
$30B
$717K 0.28%
9,217
+154
+2% +$12.1K
TPL icon
92
Texas Pacific Land
TPL
$23.5B
$706K 0.28%
14,220
LMT icon
93
Lockheed Martin
LMT
$136B
$698K 0.27%
2,174
+50
+2% +$15.8K
QCOM icon
94
Qualcomm
QCOM
$176B
$679K 0.27%
10,599
-115
-1% -$6.97K
GOOG icon
95
Alphabet (Google) Class C
GOOG
$4.32T
$631K 0.25%
12,060
-3,120
-21% -$159K
MA icon
96
Mastercard
MA
$493B
$625K 0.25%
4,127
+101
+3% +$15K
BEN icon
97
Franklin Resources
BEN
$17.2B
$607K 0.24%
14,015
+240
+2% +$10.4K
SYK icon
98
Stryker
SYK
$130B
$591K 0.23%
3,820
+2
+0.1% +$305
GD icon
99
General Dynamics
GD
$106B
$571K 0.22%
2,805
-237
-8% -$48.4K
VUG icon
100
Vanguard Morningstar Growth ETF
VUG
$231B
$562K 0.22%
23,988

Similar funds

Nicholas Hoffman & Company's Q4 2017 Portfolio in Review

As of Q4 2017, Nicholas Hoffman & Company held 173 positions worth $255M, up 7.3% from $237M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Nicholas Hoffman & Company's Q4 2017 filing shows 9 new, 70 increased, 65 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K. The largest sale was Walmart Inc, an estimated $639K.

By sector, the portfolio is most concentrated in Consumer Staples at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.

  • Nicholas Hoffman & Company's largest Q4 2017 buy was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K.
  • Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $2.37M increase.
  • Nicholas Hoffman & Company's biggest Q4 2017 reduction was Walmart Inc, cutting an estimated $639K.
  • Nicholas Hoffman & Company fully exited Celgene Corp in Q4 2017, selling an estimated $260K.
  • Nicholas Hoffman & Company's ten largest holdings make up 41% of its $255M portfolio in Q4 2017.
  • Nicholas Hoffman & Company opened 9 new positions and closed 7 in Q4 2017.
  • Nicholas Hoffman & Company's portfolio value rose 7.3% quarter-over-quarter to $255M.

Based on Nicholas Hoffman & Company's 13F filing for Q4 2017, filed 9 Feb 2018.